Senseonics Holdings, Inc. (SENS.us)今日盘中股价大涨5.35%,报收0.325美元/股。公司专注于血糖监测系统的开发和商业化,主要产品和服务包括连续葡萄糖监测系统、传感器等,主要收入来自美国以外市场。
市场分析人士认为,Senseonics在长期植入式血糖管理技术领域具有较强优势,且公司基本面向好。最新财报显示,公司虽然仍处于亏损状态,但营收水平持续增加。与此同时,行业内其他多家相关公司股价今日也出现不同程度上涨,显示市场对医疗器械行业的未来发展前景较为看好。
机构投资者方面,5家分析机构中,40%机构给予该股买入评级,20%给予持有评级。这或也反映了市场对该公司产品和长期发展潜力较为乐观的预期,成为推动股价上涨的重要因素之一。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.